{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T03:56:03Z","timestamp":1782878163803,"version":"3.54.5"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008968","name":"Istanbul Kalkinma Ajansi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008968","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Biological Macromolecules"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/j.ijbiomac.2025.142602","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T13:10:51Z","timestamp":1743253851000},"page":"142602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"P2","title":["Employing steered MD simulations for effective virtual screening: Active pharmacophore search by dynamic corrections to target MKK3-MYC interactions"],"prefix":"10.1016","volume":"310","author":[{"given":"Muhammet Eren","family":"Ulug","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saima","family":"Ikram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Sayyah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serdar","family":"Durda\u011f\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijbiomac.2025.142602_bb0005","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrclinonc.2016.66","article-title":"Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease","volume":"13","author":"Bianchini","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0010","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.681476","article-title":"Current triple-negative breast cancer subtypes: dissecting the most aggressive form of breast cancer","volume":"11","author":"Ensenyat-Mendez","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0015","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.18632\/oncotarget.12284","article-title":"Triple-negative breast cancer: is there a treatment on the horizon?","volume":"8","author":"Yao","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0020","doi-asserted-by":"crossref","DOI":"10.21037\/pcm-20-75","article-title":"Triple negative breast cancer: emerging light on the horizon\u2014a narrative review","volume":"4","author":"Bharaj","year":"2021","journal-title":"Precis. Cancer Med."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0025","doi-asserted-by":"crossref","first-page":"957","DOI":"10.3390\/cells8090957","article-title":"Mechanisms of Chemotherapy Resistance in Triple-Negative Breast Cancer\u2014How We Can Rise to the Challenge","volume":"8","author":"Nedeljkovi\u0107","year":"2019","journal-title":"Cells"},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0030","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.3390\/biom13081207","article-title":"Challenges and opportunities in developing targeted therapies for triple negative breast cancer","volume":"13","author":"Chapdelaine","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0035","article-title":"Triple-negative breast cancer: epidemiological considerations and recommendations","volume":"23 Suppl 6","author":"Boyle","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0040","doi-asserted-by":"crossref","unstructured":"K.K. Zajac, S. Malla, R.J. Babu, D. Raman, A.K. Tiwari, Ethnic disparities in the immune microenvironment of triple negative breast cancer and its role in therapeutic outcomes, Cancer Rep. (Hoboken) 6 Suppl 1 (2023). doi:https:\/\/doi.org\/10.1002\/CNR2.1779.","DOI":"10.1002\/cnr2.1779"},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0045","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.3390\/biomedicines11092411","article-title":"Long non-coding RNAs in colorectal cancer: navigating the intersections of immunity, intercellular communication, and therapeutic potential","volume":"11","author":"Shakhpazyan","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0050","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3390\/genes8060151","article-title":"MYC deregulation in primary human cancers","volume":"8","author":"Kalkat","year":"2017","journal-title":"Genes"},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0055","series-title":"Signal Transduction and Targeted Therapy","first-page":"1","article-title":"Targeting oncogenic Myc as a strategy for cancer treatment","volume":"3","author":"Chen","year":"2018"},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0060","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/nrc2231","article-title":"Reflecting on 25 years with MYC","volume":"8","author":"Meyer","year":"2008","journal-title":"Nature Reviews Cancer"},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0065","series-title":"Cell Communication and Signaling","first-page":"1","article-title":"c-MYC mediates the crosstalk between breast cancer cells and tumor microenvironment","volume":"21","author":"Gao","year":"2023"},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0070","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116324","article-title":"Discovery of the first chemical tools to regulate MKK3-mediated MYC activation in cancer","volume":"45","author":"Yang","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0075","doi-asserted-by":"crossref","first-page":"e12550","DOI":"10.1200\/JCO.2019.37.15_suppl.e12550","article-title":"MYC as a therapeutic target for the treatment of triple-negative breast cancer","volume":"37","author":"Foley","year":"2019","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0080","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/1947601910378691","article-title":"MYC and breast cancer","volume":"1","author":"Xu","year":"2010","journal-title":"Genes Cancer"},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0085","doi-asserted-by":"crossref","first-page":"13554","DOI":"10.1021\/bi00041a035","article-title":"The leucine zippers of the HLH-LZ proteins max and c-Myc preferentially form heterodimers","volume":"34","author":"Muhle-Goll","year":"1995","journal-title":"Biochemistry"},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0090","article-title":"MYC: a multipurpose oncogene with prognostic and therapeutic implications in blood malignancies","volume":"14","author":"Ahmadi","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0095","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10549-022-06673-6","article-title":"MYC as a therapeutic target for the treatment of triple-negative breast cancer: preclinical investigations with the novel MYC inhibitor, MYCi975","volume":"195","author":"Tang","year":"2022","journal-title":"Breast Cancer Res. Treat."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0100","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","article-title":"The MYC oncogene \u2014 the grand orchestrator of cancer growth and immune evasion","volume":"19","author":"Dhanasekaran","year":"2021","journal-title":"Nature Reviews Clinical Oncology"},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0105","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41568-021-00367-9","article-title":"MYC protein interactors in gene transcription and cancer","volume":"21","author":"Lourenco","year":"2021","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctrv.2021.102154","article-title":"MYC as a target for cancer treatment","volume":"94","author":"Duffy","year":"2021","journal-title":"Cancer Treat. Rev."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0115","doi-asserted-by":"crossref","first-page":"5852","DOI":"10.1038\/onc.2017.180","article-title":"OncoPPi-informed discovery of mitogen-activated protein kinase kinase 3 as a novel binding partner of c-Myc","volume":"36","author":"Ivanov","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0120","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.sbi.2005.04.002","article-title":"Multiple sequence alignments","volume":"15","author":"Wallace","year":"2005","journal-title":"Curr. Opin. Struct. Biol."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0125","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/j.str.2013.08.005","article-title":"High-resolution comparative modeling with RosettaCM","volume":"21","author":"Song","year":"2013","journal-title":"Structure"},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0130","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","article-title":"Highly accurate protein structure prediction with AlphaFold","author":"Jumper","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0135","doi-asserted-by":"crossref","first-page":"W296","DOI":"10.1093\/nar\/gky427","article-title":"SWISS-MODEL: homology modelling of protein structures and complexes","volume":"46","author":"Waterhouse","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0140","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jmb.2015.09.014","article-title":"The HADDOCK2.2 web server: user-friendly integrative modeling of biomolecular complexes","volume":"428","author":"Van Zundert","year":"2016","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0145","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.csbj.2020.06.020","article-title":"Essential site scanning analysis: a new approach for detecting sites that modulate the dispersion of protein global motions","volume":"18","author":"Kaynak","year":"2020","journal-title":"Comput. Struct. Biotechnol. J."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0150","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s41401-019-0228-6","article-title":"CB-dock: a web server for cavity detection-guided protein-ligand blind docking","volume":"41","author":"Liu","year":"2020","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0155","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3390\/ijms23020811","article-title":"The SwissSimilarity 2021 Web Tool: Novel Chemical Libraries and Additional Methods for an Enhanced Ligand-Based Virtual Screening Experience","volume":"23","author":"Bragina","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0160","doi-asserted-by":"crossref","first-page":"9954","DOI":"10.1021\/jp003020w","article-title":"Structure and dynamics of the TIP3P, SPC, and SPC\/E water models at 298 K","volume":"105","author":"Mark","year":"2001","journal-title":"J. Phys. Chem. A"},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0165","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1063\/1.449071","article-title":"The nose-hoover thermostat","volume":"83","author":"Evans","year":"1985","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0170","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1063\/1.463940","article-title":"Nos\u00e9-hoover chains: the canonical ensemble via continuous dynamics","volume":"97","author":"Martyna","year":"1992","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0175","doi-asserted-by":"crossref","first-page":"8577","DOI":"10.1063\/1.470117","article-title":"A smooth particle mesh Ewald method","volume":"103","author":"Essmann","year":"1995","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0180","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1021\/acs.jctc.8b01026","article-title":"OPLS3e: extending force field coverage for drug-like small molecules","volume":"15","author":"Roos","year":"2019","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0185","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2022.991369","article-title":"In-silico molecular modelling, MM\/GBSA binding free energy and molecular dynamics simulation study of novel pyrido fused imidazo[4,5-c]quinolines as potential anti-tumor agents","volume":"10","author":"Dasmahapatra","year":"2022","journal-title":"Front. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0190","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1002\/prot.23106","article-title":"The VSGB 2.0 model: a next generation energy model for high resolution protein structure modeling","volume":"79","author":"Li","year":"2011","journal-title":"Proteins"},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0195","article-title":"Dynamic structure-based pharmacophore models for virtual screening of small molecule libraries targeting the YB-1","author":"Oktay","year":"2023","journal-title":"BioRxiv"},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0200","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202300644","article-title":"Developing dynamic structure-based pharmacophore and ML-trained QSAR models for the discovery of novel resistance-free RET tyrosine kinase inhibitors through extensive MD trajectories and NRI analysis","volume":"19","author":"Sayyah","year":"2024","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0205","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10822-006-9087-6","article-title":"PHASE: a new engine for pharmacophore perception, 3D QSAR model development, and 3D database screening: 1. Methodology and preliminary results","volume":"20","author":"Dixon","year":"2006","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0210","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.jmgm.2018.09.014","article-title":"Targeting the NF-\u03baB\/I\u03baB\u03b1 complex via fragment-based E-pharmacophore virtual screening and binary QSAR models","volume":"86","author":"Kanan","year":"2019","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2020.107727","article-title":"Potent novel inhibitors against hepatitis C virus NS3 (HCV NS3 GT-3a) protease domain","volume":"101","author":"Ikram","year":"2020","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0220","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1021\/acsptsci.0c00210","article-title":"Hybrid in silico and TR-FRET-guided discovery of novel BCL-2 inhibitors","volume":"4","author":"Sahin","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0225","doi-asserted-by":"crossref","first-page":"91","DOI":"10.55730\/1300-0152.2686","article-title":"A novel algorithm for the virtual screening of extensive small molecule libraries against ERCC1\/XPF protein-protein interaction for the identification of therapeutic resistance-bypassing small anticancer molecules","volume":"48","author":"Ghazy","year":"2024","journal-title":"Turk. J. Biol."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2021.107876","article-title":"Screening of small molecule libraries using combined text mining, ligand- and target-driven based approaches for identification of novel granzyme H inhibitors","volume":"105","author":"Ikram","year":"2021","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0235","doi-asserted-by":"crossref","first-page":"6177","DOI":"10.1021\/jm051256o","article-title":"Extra precision glide: docking and scoring incorporating a model of hydrophobic enclosure for protein-ligand complexes","volume":"49","author":"Friesner","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0240","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1021\/acs.jctc.3c00044","article-title":"Epik: p Ka and protonation state prediction through machine learning","volume":"19","author":"Johnston","year":"2023","journal-title":"J. Chem. Theory Comput."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0245","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s10822-007-9133-z","article-title":"Epik: a software program for pK(a) prediction and protonation state generation for drug-like molecules","volume":"21","author":"Shelley","year":"2007","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0250","doi-asserted-by":"crossref","first-page":"W25","DOI":"10.1093\/nar\/gkad348","article-title":"ACFIS 2.0: an improved web-server for fragment-based drug discovery via a dynamic screening strategy","volume":"51","author":"Shi","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0255","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/jcc.20945","article-title":"CHARMM-GUI: a web-based graphical user interface for CHARMM","volume":"29","author":"Jo","year":"2008","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0260","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1063\/1.464397","article-title":"Particle mesh Ewald: an N&sdot;log(N) method for Ewald sums in large systems","volume":"98","author":"Darden","year":"1993","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0265","doi-asserted-by":"crossref","first-page":"9834","DOI":"10.1021\/jp048385l","article-title":"Early unfolding response of a stable protein domain to environmental changes\u2020","volume":"108","author":"Perera","year":"2004","journal-title":"J. Phys. Chem. A"},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0270","doi-asserted-by":"crossref","DOI":"10.1093\/bib\/bbac087","article-title":"FitDock: protein-ligand docking by template fitting","volume":"23","author":"Yang","year":"2022","journal-title":"Brief. Bioinform."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0275","doi-asserted-by":"crossref","first-page":"W159","DOI":"10.1093\/nar\/gkac394","article-title":"CB-Dock2: improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting","volume":"50","author":"Liu","year":"2022","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0280","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2019.107462","article-title":"Screening of FDA approved drugs for finding potential inhibitors against Granzyme B as a potent drug-repurposing target","volume":"95","author":"Ikram","year":"2020","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0285","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1021\/acschemneuro.8b00095","article-title":"Proposing novel MAO-B hit inhibitors using multidimensional molecular modeling approaches and application of binary QSAR models for prediction of their therapeutic activity, pharmacokinetic and toxicity properties","volume":"9","author":"Is","year":"2018","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0290","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3906\/biy-2106-61","article-title":"Binary-Qsar guided virtual screening of Fda approved drugs and compounds in clinical investigation against Sars-Cov-2 main protease","volume":"45","author":"Oktay","year":"2021","journal-title":"Turkish J. Biol."},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0295","doi-asserted-by":"crossref","first-page":"6166","DOI":"10.1038\/s41388-018-0396-8","article-title":"LINC01638 lncRNA activates MTDH-Twist1 signaling by preventing SPOP-mediated c-Myc degradation in triple-negative breast cancer","volume":"37","author":"Luo","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.ijbiomac.2025.142602_bb0300","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s10555-023-10097-z","article-title":"Combination of immune-checkpoint inhibitors and targeted therapies for melanoma therapy: the more, the better?","volume":"42","author":"Haist","year":"2023","journal-title":"Cancer Metastasis Rev."}],"container-title":["International Journal of Biological Macromolecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302503154X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S014181302503154X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T03:05:48Z","timestamp":1782875148000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S014181302503154X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5]]},"references-count":60,"alternative-id":["S014181302503154X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.142602","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.07.15.603633","asserted-by":"object"}]},"ISSN":["0141-8130"],"issn-type":[{"value":"0141-8130","type":"print"}],"subject":[],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Employing steered MD simulations for effective virtual screening: Active pharmacophore search by dynamic corrections to target MKK3-MYC interactions","name":"articletitle","label":"Article Title"},{"value":"International Journal of Biological Macromolecules","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijbiomac.2025.142602","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"142602"}}